FDA has given clearance to the Lifesys PACS, a fourth-generation PACS from Lifetrack Medical Systems Inc., based in Taguig, Philippines,
Already deployed in Southeast Asia and South Asia, Lifetrack’s patented platform aims to simplify the deployment of digital radiology, while significantly reducing costs and bringing high quality diagnostic reporting to large underserved populations.
“With this important milestone of US FDA approval, we’re very pleased to now be introducing our Lifesys RIS/PACS solution to US hospitals, clinics, and imaging centers,” says Eric Schulze, MD PhD, founder and CEO of Lifetrack. “We’ve already seen how our platform enables very rapid turnaround times of structured comprehensive diagnostic reports, which radiologists and medical providers alike appreciate and with patients being the ultimately beneficiary.”
The Lifesys platform features patented RadNav technology, which offers integrated decision support and active templates.